Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril orodispersible minitablets in children with heart failure due to dilated cardiomyopathy
NL-OMON43626Phase 2Active, not recruiting
- Sponsor
- Ethicare Clinical Trial Services
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of enalapril in dilated cardiomyopathy (DCM) and heart failure (HF) (2 arms), sponsored by Ethicare Clinical Trial Services. Primary endpoint: Primary pharmacokinetic endpoint. Started Jan 2016; status: active, not recruiting.
02
Drugs
enalapril
03
Conditions
dilated cardiomyopathy (DCM)heart failure (HF)
Beyond the preview
Go deeper on NL-OMON43626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43626.